Works matching DE "MULTIPLE sclerosis treatment"
Results: 3254
Knowledge about multiple sclerosis among Palestinian community dwellers in the West Bank.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2024, v. 32, n. 2, p. 167, doi. 10.1007/s10389-022-01803-2
- By:
- Publication type:
- Article
Innovative Complementary Cooling Intervention for Women's Multiple Sclerosis Symptoms: A Mixed-Methods Study.
- Published in:
- Journal of Holistic Nursing, 2025, v. 43, n. 1, p. 84, doi. 10.1177/08980101241292099
- By:
- Publication type:
- Article
DMSG-InfoGuide aktualisiert.
- Published in:
- Ergotherapie & Rehabilitation, 2012, v. 51, n. 4, p. 11
- Publication type:
- Article
Multiple Sklerose verstehen und behandeln.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
Cost-utility of interferon β<sub>1b</sub> in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 1, p. 50, doi. 10.1007/s10198-002-0163-0
- By:
- Publication type:
- Article
IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions.
- Published in:
- Experimental Brain Research, 2007, v. 178, n. 4, p. 462, doi. 10.1007/s00221-006-0752-8
- By:
- Publication type:
- Article
Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
- Published in:
- Archives of Dermatological Research, 2018, v. 310, n. 6, p. 475, doi. 10.1007/s00403-018-1825-9
- By:
- Publication type:
- Article
Safe Use of Systemic Interferons for Multiple Sclerosis Treatment.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 52, n. 10, p. 863, doi. 10.1007/s11094-019-1916-8
- By:
- Publication type:
- Article
Kilogram-Scale Pilot Synthesis of Fingolimod.
- Published in:
- Pharmaceutical Chemistry Journal, 2017, v. 51, n. 6, p. 476, doi. 10.1007/s11094-017-1636-x
- By:
- Publication type:
- Article
Analysis of reasons for the impossibility of creating Copaxone generics.
- Published in:
- Pharmaceutical Chemistry Journal, 2013, v. 46, n. 11, p. 656, doi. 10.1007/s11094-013-0864-y
- By:
- Publication type:
- Article
Unintended consequences.
- Published in:
- 2002
- Publication type:
- Editorial
The Effect of Implementing an Educational Program on Adherence to Treatment and Self-Compassion of Patients with Multiple Sclerosis.
- Published in:
- Archives of Anesthesiology & Critical Care, 2025, v. 11, n. 2, p. 184
- By:
- Publication type:
- Article
If You or Someone You Know Has MS.
- Published in:
- Inside MS, 2007, v. 25, n. 4, p. 10
- Publication type:
- Article
inbox.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Stem Cells and MS: Some basic definitions.
- Published in:
- Inside MS, 2007, v. 25, n. 1, p. 48
- Publication type:
- Article
What we are doing about symptoms that can't be measured easily.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
A hopeful clue for resistant MS.
- Published in:
- Inside MS, 2007, v. 25, n. 1, p. 30
- Publication type:
- Article
MS pills are making news.
- Published in:
- Inside MS, 2007, v. 25, n. 1, p. 28
- Publication type:
- Article
What's Going On with the disease-modifying drugs?
- Published in:
- Inside MS, 2006, v. 24, n. 6, p. 40
- By:
- Publication type:
- Article
MS pills show promise.
- Published in:
- Inside MS, 2006, v. 24, n. 5, p. 34
- Publication type:
- Article
Tysabri: a few answers.
- Published in:
- Inside MS, 2006, v. 24, n. 4, p. 38
- Publication type:
- Article
A new treatment option: Tysabri returns, with controls.
- Published in:
- Inside MS, 2006, v. 24, n. 4, p. 38
- Publication type:
- Article
Come on in, the water's fine!
- Published in:
- Inside MS, 2006, v. 24, n. 4, p. 34
- By:
- Publication type:
- Article
Is an oral disease-modifying drug on the horizon?
- Published in:
- Inside MS, 2006, v. 24, n. 1, p. 55
- By:
- Publication type:
- Article
Talking with Richard M. Cohen.
- Published in:
- 2006
- By:
- Publication type:
- Interview
Mixed messages about Provigil for MS fatigue.
- Published in:
- Inside MS, 2006, v. 24, n. 1, p. 29
- By:
- Publication type:
- Article
Two oral drugs for MS show promise.
- Published in:
- Inside MS, 2005, v. 23, n. 6, p. 32
- Publication type:
- Article
Know your NAbs.
- Published in:
- Inside MS, 2005, v. 23, n. 6, p. 31
- Publication type:
- Article
Advice on disease management revised and reaffirmed.
- Published in:
- Inside MS, 2005, v. 23, n. 5, p. 37
- Publication type:
- Article
Dr. John Richert heads new national department.
- Published in:
- Inside MS, 2005, v. 23, n. 3, p. 39
- Publication type:
- Article
"Action".
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 78
- By:
- Publication type:
- Article
The Stem Cell Story.
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 54
- By:
- Publication type:
- Article
Advocates visit in person.
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 40
- Publication type:
- Article
Advocates in action for Rx equality.
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 40
- Publication type:
- Article
A single person speaks out.
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 41
- Publication type:
- Article
Chapter use their resources.
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 41
- Publication type:
- Article
Betaseron for progressive MS?
- Published in:
- Inside MS, 2003, v. 21, n. 4, p. 37
- Publication type:
- Article
"Horizons".
- Published in:
- Inside MS, 2003, v. 21, n. 3, p. 78
- By:
- Publication type:
- Article
Betaseron approved for secondary-progressive MS.
- Published in:
- Inside MS, 2003, v. 21, n. 3, p. 29
- Publication type:
- Article
Avonex approved for people at "high risk" of MS.
- Published in:
- Inside MS, 2003, v. 21, n. 3, p. 28
- Publication type:
- Article
Pregnancy Hormone Holds Hope for Treatment.
- Published in:
- Inside MS, 2003, v. 21, n. 2, p. 70
- By:
- Publication type:
- Article
In the Pipe line.
- Published in:
- Inside MS, 2003, v. 21, n. 1, p. 50
- By:
- Publication type:
- Article
'Expensive'
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 78
- By:
- Publication type:
- Article
Rebif [in Context].
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 45
- By:
- Publication type:
- Article
News.
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 38
- Publication type:
- Article
GETTING DISEASE-MODIFYING DRUGS IN THE U.K.
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 32
- By:
- Publication type:
- Article
GETTING DISEASE-MODIFYING DRUGS IN THE U.S.
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 30
- By:
- Publication type:
- Article
I MISS MY MOTHER SO MUCH.
- Published in:
- Inside MS, 2002, v. 20, n. 3, p. 20
- By:
- Publication type:
- Article
Study shows Copaxone reduces "black holes" in the brain.
- Published in:
- Inside MS, 2002, v. 20, n. 1, p. 37
- Publication type:
- Article
Promising results in early Antegren trial.
- Published in:
- Inside MS, 2002, v. 20, n. 1, p. 36
- Publication type:
- Article